As AI moves beyond technical teams, LuminosAI expands access to help a much larger group of builders test whether their AI works as intended. LuminosAI announced that it is opening its AI evaluation platform to everyone through a new free tier and fully self-serve onboarding, expanding access to technology the company has used for years

Rewards | Pre-Competition Warm-Up Challenge: post and earn up to 50,000 points*! Trailblazer_Empire [Part 08 ] ViTrox Corporation Berhad is increasingly becoming a technology company built around machine vision, AI and intelligent manufacturing rather than merely an inspection-equipment manufacturer. Its core value proposition sits at the intersection of optics, semiconductor inspection, automation and software. ViTrox's

Zeta Global to Acquire Senso, Adding AI Engineering and Frontier-Model Connectivity to Its Intelligent AI Infrastructure Senso will strengthen Zeta’s ability to bring customer intelligence to the AI platforms shaping discovery Zeta Global (NYSE: ZETA), the intelligent AI infrastructure company, today announced that it has entered into a definitive agreement to acquire Senso, a Y

Engineers increasingly use coding assistance tools to accelerate their development workflows. Today, Amazon SageMaker AI optimized generative AI inference introduces the aws-ai-ml skill, available through the Agent Toolkit for AWS. This skill gives coding agents like Kiro, Claude Code, and Codex deep expertise in inference optimization and benchmarking. Install the skill, and your existing agent

The Gene Prediction Tools Market was valued at USD 188.60 Million in 2025 and is projected to reach USD 1,026.26 Million by 2035, registering a CAGR of 18.46% from 2026 to 2035. The Gene Prediction Tools Market is steadily reshaping genome analysis by moving researchers from manual annotation and rule-based gene finders toward AI-driven platforms

In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI. When there are breast imaging

Enterprise AI is moving into a new phase as organizations shift attention from proving AI concepts to putting them into everyday business operations. The change is creating a different implementation challenge. AI prototypes can demonstrate value in weeks. But turning them into secure and dependable production systems requires deeper work across enterprise data, technology infrastructure

When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Picture it: a suited exec walks onto a stage and announces a new game about influencing and controlling people, about good and evil. And the clincher: it'll all be driven by machine learning. In 2026, that game